Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Adbri Limited stock logo
ADBCF
Adbri
$2.05
$2.05
$1.27
$2.05
N/AN/A750 shsN/A
Adbri Limited stock logo
ADLDY
Adbri
$7.83
$7.82
$3.93
$8.34
N/AN/A688 shs1 shs
Chevron Co. stock logo
CVX
Chevron
$165.27
+1.0%
$156.35
$139.62
$171.70
$306.95B1.128.46 million shs9.69 million shs
HSM
Helius Medical Technologies
C$18.35
C$14.26
C$40.00
C$42.54MN/A3,578 shs930 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Adbri Limited stock logo
ADBCF
Adbri
0.00%0.00%0.00%0.00%+102.97%
Adbri Limited stock logo
ADLDY
Adbri
0.00%0.00%0.00%+0.83%+92.50%
Chevron Co. stock logo
CVX
Chevron
+0.97%+4.94%+6.41%+10.81%-0.43%
HSM
Helius Medical Technologies
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Adbri Limited stock logo
ADBCF
Adbri
N/AN/AN/AN/AN/AN/AN/AN/A
Adbri Limited stock logo
ADLDY
Adbri
N/AN/AN/AN/AN/AN/AN/AN/A
Chevron Co. stock logo
CVX
Chevron
4.8037 of 5 stars
3.42.05.00.02.52.53.1
HSM
Helius Medical Technologies
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Adbri Limited stock logo
ADBCF
Adbri
1.50
ReduceN/AN/A
Adbri Limited stock logo
ADLDY
Adbri
N/AN/AN/AN/A
Chevron Co. stock logo
CVX
Chevron
2.74
Moderate Buy$184.7511.79% Upside
HSM
Helius Medical Technologies
N/AN/AN/AN/A

Current Analyst Ratings

Latest CVX, TON, HSM, ADLDY, and ADBCF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Chevron Co. stock logo
CVX
Chevron
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$180.00 ➝ $204.00
4/15/2024
Chevron Co. stock logo
CVX
Chevron
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$170.00 ➝ $174.00
4/11/2024
Chevron Co. stock logo
CVX
Chevron
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Sector Outperform$170.00 ➝ $195.00
4/10/2024
Chevron Co. stock logo
CVX
Chevron
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$203.00
4/9/2024
Chevron Co. stock logo
CVX
Chevron
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$185.00 ➝ $197.00
4/5/2024
Chevron Co. stock logo
CVX
Chevron
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$168.00 ➝ $156.00
4/4/2024
Chevron Co. stock logo
CVX
Chevron
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$185.00 ➝ $198.00
4/1/2024
Chevron Co. stock logo
CVX
Chevron
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/20/2024
Chevron Co. stock logo
CVX
Chevron
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$195.00 ➝ $200.00
3/14/2024
Chevron Co. stock logo
CVX
Chevron
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$188.00 ➝ $180.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Adbri Limited stock logo
ADBCF
Adbri
N/AN/AN/AN/AN/AN/A
Adbri Limited stock logo
ADLDY
Adbri
N/AN/AN/AN/AN/AN/A
Chevron Co. stock logo
CVX
Chevron
$200.95B1.53$22.58 per share7.32$85.78 per share1.93
HSM
Helius Medical Technologies
C$477K0.00N/A5.71C$3.61 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Adbri Limited stock logo
ADBCF
Adbri
N/A$0.229.35N/AN/AN/AN/AN/A
Adbri Limited stock logo
ADLDY
Adbri
N/AN/A0.00N/AN/AN/AN/AN/A
Chevron Co. stock logo
CVX
Chevron
$21.37B$11.3614.5510.552.4010.63%15.24%9.56%4/26/2024 (Confirmed)
HSM
Helius Medical Technologies
N/A-C$11.02N/AN/AN/AN/AN/AN/AN/A

Latest CVX, TON, HSM, ADLDY, and ADBCF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/26/2024N/A
Chevron Co. stock logo
CVX
Chevron
$3.06$2.87-$0.19N/AN/AN/A  
2/2/202412/31/2023
Chevron Co. stock logo
CVX
Chevron
$3.19$3.45+$0.26$5.68$50.93 billion$47.18 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Adbri Limited stock logo
ADBCF
Adbri
$0.178.05%N/A75.29%N/A
Adbri Limited stock logo
ADLDY
Adbri
N/AN/AN/AN/AN/A
Chevron Co. stock logo
CVX
Chevron
$6.523.95%+5.39%57.39%37 Years
HSM
Helius Medical Technologies
N/AN/AN/AN/AN/A

Latest CVX, TON, HSM, ADLDY, and ADBCF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/2/2024
Chevron Co. stock logo
CVX
Chevron
Quarterly$1.634.28%2/15/20242/16/20243/11/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Adbri Limited stock logo
ADBCF
Adbri
N/AN/AN/A
Adbri Limited stock logo
ADLDY
Adbri
N/AN/AN/A
Chevron Co. stock logo
CVX
Chevron
0.13
1.27
1.01
HSM
Helius Medical Technologies
0.74
4.20
3.58

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Adbri Limited stock logo
ADBCF
Adbri
9.15%
Adbri Limited stock logo
ADLDY
Adbri
N/A
Chevron Co. stock logo
CVX
Chevron
72.42%
HSM
Helius Medical Technologies
N/A

Insider Ownership

CompanyInsider Ownership
Adbri Limited stock logo
ADBCF
Adbri
N/A
Adbri Limited stock logo
ADLDY
Adbri
N/A
Chevron Co. stock logo
CVX
Chevron
0.18%
HSM
Helius Medical Technologies
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Adbri Limited stock logo
ADBCF
Adbri
1,600N/AN/ANot Optionable
Adbri Limited stock logo
ADLDY
Adbri
1,600N/AN/ANot Optionable
Chevron Co. stock logo
CVX
Chevron
45,6001.86 billion1.85 billionOptionable
HSM
Helius Medical Technologies
192.32 millionN/ANot Optionable

CVX, TON, HSM, ADLDY, and ADBCF Headlines

SourceHeadline
Helius Medical Technologies (HSDT) Price Target Decreased by 9.73% to 15.78Helius Medical Technologies (HSDT) Price Target Decreased by 9.73% to 15.78
msn.com - April 17 at 2:10 PM
Helius Medical Technologies: Strides Towards Reimbursement for Innovative PoNS Therapy Amidst Financial ChallengesHelius Medical Technologies: Strides Towards Reimbursement for Innovative PoNS Therapy Amidst Financial Challenges
msn.com - April 1 at 10:19 AM
Recap: Helius Medical Tech Q4 EarningsRecap: Helius Medical Tech Q4 Earnings
benzinga.com - March 28 at 9:03 PM
Helius Medical Technologies Boosts Finance with Stock SalesHelius Medical Technologies Boosts Finance with Stock Sales
msn.com - February 10 at 7:54 AM
Helius Medical Technologies Inc Class A HSDTHelius Medical Technologies Inc Class A HSDT
morningstar.com - November 1 at 5:39 AM
Helius Medical Technologies GAAP EPS of -$0.06 beats by $0.06, revenue of $0.25M beats by $0.06MHelius Medical Technologies GAAP EPS of -$0.06 beats by $0.06, revenue of $0.25M beats by $0.06M
msn.com - August 10 at 5:17 PM
Helius Medical Tech: Q1 Earnings InsightsHelius Medical Tech: Q1 Earnings Insights
msn.com - May 11 at 9:29 PM
Earnings Outlook For Helius Medical TechEarnings Outlook For Helius Medical Tech
msn.com - May 10 at 2:09 PM
Helius Medical Tech Stock (NASDAQ:HSDT), Guidance and ForecastHelius Medical Tech Stock (NASDAQ:HSDT), Guidance and Forecast
benzinga.com - April 13 at 1:22 AM
Helius Medical Techs Return On Capital Employed InsightsHelius Medical Tech's Return On Capital Employed Insights
msn.com - March 14 at 3:46 PM
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
yahoo.com - January 23 at 7:54 AM
Looking Into Helius Medical Techs Return On Capital EmployedLooking Into Helius Medical Tech's Return On Capital Employed
msn.com - December 23 at 12:00 PM
Helius Medical Technologies, Inc. (HSDT) Moves to Buy: Rationale Behind the UpgradeHelius Medical Technologies, Inc. (HSDT) Moves to Buy: Rationale Behind the Upgrade
msn.com - November 18 at 3:44 AM
Helius Medical TechnologiesHelius Medical Technologies
forbes.com - October 25 at 10:20 PM
Helius Medical Technologies Inc Reports Second Quarter 2022 Financial ResultsHelius Medical Technologies Inc Reports Second Quarter 2022 Financial Results
ptproductsonline.com - August 15 at 11:41 PM
Emerging Markets Report: The Air We ShareEmerging Markets Report: The Air We Share
nz.finance.yahoo.com - May 4 at 11:09 PM
Spotify becomes first music streamer to launch on RobloxSpotify becomes first music streamer to launch on Roblox
yahoo.com - May 4 at 11:09 PM
Globenewswire | Financial PostGlobenewswire | Financial Post
financialpost.com - May 4 at 11:09 PM
Helius Medical Shares Up After U.S. Introduction of Multiple Sclerosis DeviceHelius Medical Shares Up After U.S. Introduction of Multiple Sclerosis Device
marketwatch.com - April 26 at 7:36 PM
Were Keeping An Eye On Helius Medical Technologies (NASDAQ:HSDT) Cash Burn RateWe're Keeping An Eye On Helius Medical Technologies' (NASDAQ:HSDT) Cash Burn Rate
finance.yahoo.com - August 18 at 3:28 PM
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - August 12 at 4:26 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Adbri logo

Adbri

OTCMKTS:ADBCF
Adbri Limited manufactures and distributes construction materials in Australia. The company operates in two segments: Cement, Lime, Concrete and Aggregates; and Masonry. It provides cement, lime, premixed concrete, aggregates, and sand; various concrete bricks, besser blocks, pavers, and retaining wall blocks; and industrial minerals comprising agricultural lime products, stockfield minerals and fillers for glass manufacturing, and quick and hydrated lime for industrial processing and water treatment applications. The company offers its products to residential and non-residential construction, engineering construction, industrial manufacturing, and mining markets. Adbri Limited was founded in 1882 and is based in Adelaide, Australia.
Adbri logo

Adbri

OTCMKTS:ADLDY
Adbri Limited manufactures and distributes construction materials in Australia. The company operates in two segments: Cement, Lime, Concrete and Aggregates; and Masonry. It provides cement, lime, premixed concrete, aggregates, and sand; various concrete bricks, besser blocks, pavers, and retaining wall blocks; and industrial minerals comprising agricultural lime products, stockfield minerals and fillers for glass manufacturing, and quick and hydrated lime for industrial processing and water treatment applications. The company offers its products to residential and non-residential construction, engineering construction, industrial manufacturing, and mining markets. Adbri Limited was founded in 1882 and is based in Adelaide, Australia.
Chevron logo

Chevron

NYSE:CVX
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.

Helius Medical Technologies

TSE:HSM
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.